About Curetis
Curetis is a company based in Holzgerlingen (Germany) founded in 2007 was acquired by OpGen in September 2019.. Curetis has raised $127.14 million across 14 funding rounds from investors including Qiagen, OpGen and European Investment Bank. The company has 55 employees as of December 31, 2020. Curetis offers products and services including Unyvero and Unyvero A50 Solution. Curetis operates in a competitive market with competitors including Prenetics, Inflammatix, Karius, Day Zero Diagnostics and MeMed, among others.
- Headquarter Holzgerlingen, Germany
- Employees 55 as on 31 Dec, 2020
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Curetis Gmbh.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Curetis
Curetis offers a comprehensive portfolio of products and services, including Unyvero and Unyvero A50 Solution. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Rapid molecular tool for detecting pathogens in infections.
Provides fast results for clinical syndromes with minimal training.
Unlock access to complete
Unlock access to complete
Funding Insights of Curetis
Curetis has successfully raised a total of $127.14M across 14 strategic funding rounds. The most recent funding activity was a Grant round of $409.68 thousand completed in September 2020. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 14
- Last Round Grant — $409,682
-
First Round
First Round
(01 Jun 2008)
- Investors Count 12
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep, 2020 | Amount | Grant - Curetis | Valuation |
investors |
|
| Jul, 2020 | Amount | Debt – Conventional - Curetis | Valuation |
investors |
|
| May, 2019 | Amount | Debt – Conventional - Curetis | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Curetis
Curetis has secured backing from 13 investors, including institutional and venture fund investors. Prominent investors backing the company include Qiagen, OpGen and European Investment Bank. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Finance and advisory services for infrastructure projects are provided.
|
Founded Year | Domain | Location | |
|
Early to mid stage life sciences-focused VC firm investing in geographies such as Europe
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on lifescience and healthcare sectors
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Curetis
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Curetis
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Curetis Comparisons
Competitors of Curetis
Curetis operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Prenetics, Inflammatix, Karius, Day Zero Diagnostics and MeMed, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Health risks are identified through online genetic and diagnostic testing.
|
|
| domain | founded_year | HQ Location |
Provider of diagnostic solutions for systemic infections
|
|
| domain | founded_year | HQ Location |
Developer of a non-invasive pathogen blood test for the detection of infectious diseases
|
|
| domain | founded_year | HQ Location |
Genome sequencing diagnostics for infectious diseases are developed.
|
|
| domain | founded_year | HQ Location |
Provider of machine learning based diagnostic solutions for infectious diseases
|
|
| domain | founded_year | HQ Location |
Portable PCR diagnostics for infectious diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Curetis
Frequently Asked Questions about Curetis
When was Curetis founded?
Curetis was founded in 2007 and raised its 1st funding round 1 year after it was founded.
Where is Curetis located?
Curetis is headquartered in Holzgerlingen, Germany. It is registered at Holzgerlingen, Baden-wurttemberg, Germany.
Who is the current CEO of Curetis?
Raju Jha is the current CEO of Curetis.
Is Curetis a funded company?
Curetis is a funded company, having raised a total of $127.14M across 14 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $5.58M, raised on Jun 01, 2008.
How many employees does Curetis have?
As of Dec 31, 2020, the latest employee count at Curetis is 55.
What does Curetis do?
The company was founded in 2007 in Holzgerlingen, Germany, and operates in the molecular diagnostics sector. A platform for detecting infectious diseases through multiparameter PCR testing is developed, targeting bacterial infections in hospitalized patients. The Unyvero A50 System is utilized with various cartridges to identify pathogens and resistance genes for conditions like pneumonia and implant infections, with results obtained in 4-5 hours.
Who are the top competitors of Curetis?
Curetis's top competitors include Visby Medical, Inflammatix and Prenetics.
What products or services does Curetis offer?
Curetis offers Unyvero and Unyvero A50 Solution.
Who are Curetis's investors?
Curetis has 13 investors. Key investors include Qiagen, OpGen, European Investment Bank, KfW, and BMBF.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.